Table 3

Operating characteristics of the continuous reassessment model

Starting dose level 1, dose-skipping not allowed, 3 dose levels, maximum 24 participants.
Skeleton (a priori probabilities of DLE) = 0.05, 0.11, 0.20
target DLE rate=no greater than 20%
Dose level
123
Scenario 1: recommendation (%)2.524.573.0
Scenario 2: recommendation (%)22.546.531.0
Scenario 3: recommendation (%)0.03.396.7
Scenario 1: true probabilities=a priori probabilities
Scenario 2: true probabilities=0.10, 0.20, 0.30
Scenario 3: true probabilities=0.02, 0.05, 0.10
  • DLE, dose-limiting event.